Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Cullinan Therapeutics Inc
(NQ:
CGEM
)
18.89
+2.22 (+13.32%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,173,726
Open
16.69
Bid (Size)
18.57 (1)
Ask (Size)
18.89 (2)
Prev. Close
16.67
Today's Range
16.53 - 19.55
52wk Range
7.640 - 20.62
Shares Outstanding
199,873,683
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Why Is Cullinan Therapeutics Stock Trading Higher On Wednesday?
Today 14:29 EDT
Explore the use of Amgen's Blincyto in treating severe systemic sclerosis, shedding light on Cullinan Therapeutics' CLN-978 potential for autoimmune diseases, particularly systemic lupus...
Via
Benzinga
Hilton Worldwide Reports Upbeat Results, Joins Hasbro, Vertiv Holdings And Other Big Stocks Moving Higher On Wednesday
Today 11:19 EDT
Via
Benzinga
Performance
YTD
+78.38%
+78.38%
1 Month
+11.58%
+11.58%
3 Month
+51.12%
+51.12%
6 Month
+120.42%
+120.42%
1 Year
+76.87%
+76.87%
More News
Read More
Cullinan Therapeutics to Present Clinical Data from Phase 1 Study Evaluating Novel Anti-MICA/B Antibody, CLN-619, as Monotherapy and in Combination with a Checkpoint Inhibitor in Patients with Advanced Solid Tumors at ASCO 2024
Today 10:09 EDT
From
Cullinan Therapeutics, Inc.
Via
GlobeNewswire
Cullinan Oncology: Q4 Earnings Insights
March 14, 2024
Via
Benzinga
Recap: Cullinan Oncology Q3 Earnings
November 08, 2023
Via
Benzinga
Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
April 17, 2024
Via
Benzinga
United Airlines Reports Upbeat Results, Joins Children's Place, Interactive Brokers And Other Big Stocks Moving Higher On Wednesday
April 17, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
April 16, 2024
Via
Benzinga
Cullinan Shifts Focus From Oncology To Autoimmune Disorders, Raises $280M Via Equity
April 16, 2024
Via
Benzinga
UnitedHealth Reports Upbeat Earnings, Joins Cullinan Oncology, Ericsson And Other Big Stocks Moving Higher On Tuesday
April 16, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Cullinan Management Inc. (NASDAQ: CGEM) Records 52-Week High Tuesday Morning
April 16, 2024
Via
Investor Brand Network
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
April 16, 2024
Via
Benzinga
Cullinan Therapeutics Announces Strategic Expansion into Autoimmune Diseases
April 16, 2024
From
Cullinan Therapeutics, Inc.
Via
GlobeNewswire
Cullinan Therapeutics Announces Oversubscribed $280 million Private Placement
April 16, 2024
From
Cullinan Therapeutics, Inc.
Via
GlobeNewswire
CGEM Stock Earnings: Cullinan Oncology Beats EPS for Q4 2023
March 14, 2024
Via
InvestorPlace
Cullinan Oncology Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
March 14, 2024
From
Cullinan Oncology, Inc.
Via
GlobeNewswire
Cullinan Oncology Announces U.S. FDA Clearance of Investigational New Drug Application for Novel MICA/B Antibody, CLN-619, for Relapsed/Refractory Multiple Myeloma
March 01, 2024
From
Cullinan Oncology, Inc.
Via
GlobeNewswire
Cullinan Oncology to Participate in Upcoming Investor Conferences
February 27, 2024
From
Cullinan Oncology, Inc.
Via
GlobeNewswire
Why Super Micro Computer Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
January 30, 2024
Via
Benzinga
Cullinan Oncology to Present at the 42nd Annual J.P. Morgan Healthcare Conference
December 18, 2023
From
Cullinan Oncology, Inc.
Via
GlobeNewswire
Cullinan Oncology Announces First Patient Dosed in Phase 1 Trial Evaluating CLN-617, a Novel Fusion Protein Uniquely Harnessing Both IL-2 and IL-12 Cytokines
December 14, 2023
From
Cullinan Oncology, Inc.
Via
GlobeNewswire
Cullinan Oncology Provides Corporate Update and Reports Third Quarter 2023 Financial Results
November 08, 2023
From
Cullinan Oncology, Inc.
Via
GlobeNewswire
Cullinan Oncology to Present Data Demonstrating Progress Across Its Broad Immunotherapy-Pipeline at SITC 2023
November 03, 2023
From
Cullinan Oncology, Inc.
Via
GlobeNewswire
Cullinan Oncology to Participate in Upcoming Investor Conferences
October 30, 2023
From
Cullinan Oncology, Inc.
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For October 6, 2023
October 06, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.